HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/5/G1165    most recent 00596.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Viswanathan, V. K. Articles by Hecht, G. Search for Related Content PubMed PubMed Citation Articles by Viswanathan, V. K. Articles by Hecht, G.

MUCOSAL BIOLOGY

Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis

Department of Medicine, Section of Digestive Diseases and Nutrition, University of Illinois and Jesse Brown Chicago Veterans Affairs Medical Center, Chicago, Illinois

Submitted 20 December 2007 ; accepted in final form 17 March 2008

Enteropathogenic Escherichia coli (EPEC) is a diarrheagenic pathogen that perturbs intestinal epithelial function. Many of the alterations in the host cells are mediated by effector molecules that are secreted directly into epithelial cells by the EPEC type III secretion system. The secreted effector molecule EspF plays a key role in redistributing tight junction proteins and altering epithelial barrier function. EspF has also been shown to localize to mitochondria and trigger membrane depolarization and eventual host cell death. The relationship, if any, between EspF-induced host cell death and epithelial barrier disruption is presently not known. Site-directed mutation of leucine 16 (L16E) of EspF impairs both mitochondrial localization and consequent host cell death. Although the mutation lies within a region critical for type III secretion, EspF(L16E) is secreted efficiently from EPEC. Despite its inability to promote cell death, EspF(L16E) was not impaired for tight junction alteration or barrier disruption. Consistent with this, the pan-caspase inhibitor Q-VD-OPH, despite reducing EPEC-induced host cell death, had no effect on infection-mediated barrier function alteration. Thus EPEC alters the epithelial barrier independent of its ability to induce host cell death.

tight junction; pathogenesis; EspF

This article has been cited by other articles:

				V. S. Conlin, X. Wu, C. Nguyen, C. Dai, B. A. Vallance, A. M. J. Buchan, L. Boyer, and K. Jacobson Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G735 - G750. [Abstract] [Full Text] [PDF]